Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients

BACKGROUND: Therapeutic drug monitoring (TDM) may represent an invaluable tool for optimizing antimicrobial therapy in septic patients, but extensive use is burdened by barriers. The aim of this study was to assess the impact of a newly established expert clinical pharmacological advice (ECPA) progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatti, Milo, Cojutti, Pier Giorgio, Bartoletti, Michele, Tonetti, Tommaso, Bianchini, Amedeo, Ramirez, Stefania, Pizzilli, Giacinto, Ambretti, Simone, Giannella, Maddalena, Mancini, Rita, Siniscalchi, Antonio, Viale, Pierluigi, Pea, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199203/
https://www.ncbi.nlm.nih.gov/pubmed/35701812
http://dx.doi.org/10.1186/s13054-022-04050-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199203/
https://www.ncbi.nlm.nih.gov/pubmed/35701812
http://dx.doi.org/10.1186/s13054-022-04050-9

Ejemplares similares